Latest News | Akums Gets Patent for Formulation to Manage Sickle Cell Disease

New Delhi, Sep 13 (PTI) Akums Drugs and Pharmaceuticals on Friday said it has received patent for a formulation for Sickle Cell Disease (SCD).

The company has received a patent from India patent office for its room temperature stable oral suspension of Hydroxyurea, a formulation aimed at managing SCD.

Also Read | Kolkata Fatafat Result Chart Online: Looking for Kolkata FF Satta Matka Winning Numbers? Beware of Unauthentic and Fraud Websites.

"Our constant endeavor is to work on affordable medicines for Orphan Drugs and reduce dependency on imported medicines ensuring patient safety from rare diseases with timely and necessary treatment," Akums Managing Director Sanjeev Jain said in a statement.

SCD, a genetic blood disorder, leads to severe health complications such as anaemia, frequent pain episodes and other debilitating symptoms, affecting millions worldwide, especially in India and Africa.

Also Read | What Is Extreme Weather Phenomenon 'Vb' That Caused Floods in Europe? Here's Everything To Know About Rare 'Five B' Weather Conditions.

Akums said its formulation will come at a fraction of the cost of imported Hydroxyurea solution.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)